Skip to main content
. 2017 Nov 15;2017(11):CD012825. doi: 10.1002/14651858.CD012825
Drug class Outcomes Illustrative comparative risks (95% CI) Relative effect (95% CI) Number of participants
(studies)
Quality of the evidence (GRADE) Comment
Intervention + usual care Usual care alone
Recurrent stroke
Cardiovascular event
Infections
SAEs*
Cardiovascular death
All cause death